Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.23453 | 50 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.1605 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.19209 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.07065 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.12571 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.32997 | 51 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.33422 | 52 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.17549 | 50 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.16783 | 50 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.19242 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.17884 | 50 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.16982 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.20044 | 50 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.59556 | 60 |